Crossmark

Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer

Crossref DOI link: https://doi.org/10.1186/s12885-019-5320-2

Published Online: 2019-02-04

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

König, Lisa

Mairinger, Fabian D.

Hoffmann, Oliver

Bittner, Ann-Kathrin

Schmid, Kurt W.

Kimmig, Rainer

Kasimir-Bauer, Sabine

Bankfalvi, Agnes
License Information

Text and Data Mining valid from 2019-02-04
More Information

Article History

Received: 7 July 2018

Accepted: 25 January 2019

First Online: 4 February 2019

Ethics approval and consent to participate

: All patients gave written informed consent for use of their tumor tissue for research purposes. The study was approved by the institutional ethics committee from the University Hospital Essen (16–6915-BO) and fully conforms to the principles outlined in the declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below